ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Session » SLE – Etiology & Pathogenesis Poster

Date: Friday, November 6, 2020

Time: 9:00AM-11:00AM

Meeting: ACR Convergence 2020

9:00AM-11:00AM
Abstract Number: 0286
An SLE-linked ITGAM Gene Variant Changes Mac-1 Structure, Signaling, and Surface Expression and Enhances IFNg Production and Antigen Presentation by B Cells
9:00AM-11:00AM
Abstract Number: 0295
CCL3L3–null Status May Predispose to Systemic Lupus Erythematosus and Non-scarring Alopecia
9:00AM-11:00AM
Abstract Number: 0293
Contraction of the Stool Taxa Clostridia Is Associated with the Development of Clinical Disease Among Anti-Ro+ Mothers of Children with Neonatal Lupus
9:00AM-11:00AM
Abstract Number: 0285
CXCL13 Neutralization Reduces Neuropsychiatric Manifestations in MRL/lpr Mice
9:00AM-11:00AM
Abstract Number: 0289
Endogenous Interferon-β and Low IL-4R on Transitional B Cells Promotes Lupus Nephritis
9:00AM-11:00AM
Abstract Number: 0292
Exhausted pSTAT5-IFNα Signaling Pathways in SLE Patients Are Correlated with Age-associated B Cells and Disease Activity
9:00AM-11:00AM
Abstract Number: 0300
Exposure to Topical Antimicrobials Reduces Inflammatory Gene Expression in Cutaneous Lupus Lesional Skin
9:00AM-11:00AM
Abstract Number: 0282
Expression of the cGAMP Transporter SLC19A1 Is Altered in Systemic Lupus Erythematosus
9:00AM-11:00AM
Abstract Number: 0301
Genetic Associations and Polygenic Risk Assessment in Incomplete Lupus Erythematosus
9:00AM-11:00AM
Abstract Number: 0283
Genome-wide DNA Methylation Analysis in Lupus Keratinocytes Identifies Differential Methylation of Genes That Regulate Apoptosis
9:00AM-11:00AM
Abstract Number: 0296
Investigating the Differences in ANA Specificities Between Asymptomatic and Symptomatic ANA+ Individuals
9:00AM-11:00AM
Abstract Number: 0298
Local Genetic Ancestry Associations with Clinical Features of Systemic Lupus Erythematosus
9:00AM-11:00AM
Abstract Number: 0302
Longitudinal Study of Acute SLE Flare Reveals Dynamic Changes in Multiple Immune Cell Subsets
9:00AM-11:00AM
Abstract Number: 0284
Oxidative DNA Damage Accelerates Skin Inflammation in Pristane-induced Lupus Model
9:00AM-11:00AM
Abstract Number: 0287
RNA Externalized by Neutrophil Extracellular Traps Promotes Inflammatory Pathways in Endothelial Cells
9:00AM-11:00AM
Abstract Number: 0290
Role of Protein Tyrosine Phosphatase 1B (PTP1B) in Endothelial-to-Mesenchymal Transition (EndoMT) Promoted by Inflammation: Implications for SLE
9:00AM-11:00AM
Abstract Number: 0291
SLAMF7 and CD38 on NK Cells Represent Potential New Therapeutic Targets for Systemic Lupus Erythematosus
9:00AM-11:00AM
Abstract Number: 0303
SLE Patients Stratify into Distinct Clusters Based on Their Peripheral Blood Immunologic Phenotype During Acute Flare
9:00AM-11:00AM
Abstract Number: 0288
Targeted Sequencing Revealed Novel Candidate Genetic Contributions to Lupus Nephritis in a Cohort of Swedish Patients with Systemic Lupus Erythematosus
9:00AM-11:00AM
Abstract Number: 0299
The Minor Protective Allele at rs1876453 Is Associated with Increased Age of Onset of Systemic Lupus Erythematosus
9:00AM-11:00AM
Abstract Number: 0294
Tired T-Cells and Monocytes with Malaise: Investigating the Links Between Cellular Iron Deficiency and Mitochondrial Dysfunction in Systemic Lupus Erythematosus
9:00AM-11:00AM
Abstract Number: 0297
Towards a Glucocorticoid Exposure Signature in SLE: Effects of Type I Interferon
9:00AM-11:00AM
Abstract Number: 0304
Type I Interferon Inhibits Glucocorticoid-Induced Leucine Zipper (GILZ) Expression and Upregulation by Glucocorticoids

« View all sessions from this meeting

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology